This inventor holds 3 USPTO granted patents. Top assignee: The University of Chicago. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2002
Title: Edward N Timofeev: Innovator in Oligonucleotide Technologies
Introduction
Edward N Timofeev is a prominent inventor based in Moscow, Russia, known for his significant contributions to the field of oligonucleotide technologies. With a total of three patents to his name, Timofeev has developed innovative methods that enhance the detection and immobilization of nucleic acids.
Latest Patents
Timofeev's latest patents include a rapid method to detect duplex formation in sequencing by hybridization methods. This method facilitates the intercalation of a fluorescent dye between the base planes of the duplex formed by complementary, single-stranded oligonucleotide molecules. Another notable patent involves constructing containment structures for reagent interaction, which allows for the creation of oligonucleotide matrices by polymerizing light-sensitive fluids into discrete units. Additionally, he has developed methods for immobilizing nucleic acids on a gel substrate, which includes modifying oligonucleotide molecules to create chemically active groups for labeling and immobilization.
Career Highlights
Edward N Timofeev is affiliated with the University of Chicago, where he continues to advance research in the field of molecular biology. His work has been instrumental in developing techniques that improve the efficiency and accuracy of nucleic acid interactions.
Collaborations
Timofeev has collaborated with notable scientists such as Andrei Darievich Mirzabekov and Valentine V Shick, contributing to the advancement of research in oligonucleotide technologies.
Conclusion
Edward N Timofeev's innovative work in oligonucleotide technologies has made a significant impact in the field of molecular biology. His patents reflect a commitment to advancing scientific knowledge and improving methodologies in nucleic acid research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
